Medexus Pharmaceuticals Inc. (MEDXF)
| Previous Close | 1.5000 |
| Open | 1.5400 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.5400 - 1.5400 |
| 52 Week Range | 1.4300 - 6.7900 |
| Volume | |
| Avg. Volume | 4,537 |
| Market Cap | 30.727M |
| Beta (5Y Monthly) | 1.10 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Medexus Generates Revenue of US$76.7 Million in Fiscal Year 2022 and US$20.3 million in Fiscal Q4 (Strongest Q4 Revenue in Company History)
Management to host conference call at 8:00 AM Eastern Time on Thursday, June 23, 2022TORONTO and CHICAGO, June 22, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) today announced its operating and financial results and provided a business update for the company’s fourth fiscal quarter and fiscal year ended March 31, 2022. All dollar amounts in this press release are in United States dollars unless specified otherwise. Financial Highlights Delivered total reve
- GlobeNewswire
Medexus Schedules Fourth Quarter and Fiscal Year 2022 Conference Call
TORONTO and CHICAGO, June 14, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, June 23, 2022 to discuss Medexus’s results for its fourth quarter and fiscal year ended March 31, 2022. Medexus expects to file its financial statements and MD&A after markets close on June 22, 2022. To participate in the call, please dial the following numbers: 888-506-0062 (toll-free) for Canadian and U.S. caller
- GlobeNewswire
Treosulfan Pivotal Study Results Published
Study’s primary endpoint and key secondary endpoints were met Study found event-free survival and overall survival superior after treosulfan compared to RIC busulfan, also found non-relapse mortality lower in treosulfan arm than busulfan arm Study results accepted for publication with American Journal of Hematology, now available online Medexus to host webconference with key opinion leader to discuss data on June 6, 2022 at 4:00 PM Eastern Time TORONTO and CHICAGO, June 06, 2022 (GLOBE NEWSWIRE)
